GTBPVSLEXX• 12 Months (Normalized)
GTBP vs LEXX (GT Biopharma Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+832.98%
GT Biopharma Inc.
Normalized Baseline0.00%
LEXX Performance $3.24
-85.9%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+918.88 pts
GTBP outperforming by 918.88 percentage points
GTBPLEXX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | GTBP Price | GTBP Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +832.98% | $3.24 | -85.90% | +918.88% |
| Sep 21, 2026 | $7.18 | +843.50% | $3.43 | -85.08% | +928.58% |
| Sep 18, 2026 | $7.16 | +840.87% | $3.24 | -85.88% | +926.75% |
| Sep 17, 2026 | $7.49 | +884.23% | $3.29 | -85.66% | +969.89% |
| Sep 16, 2026 | $7.81 | +926.28% | $3.10 | -86.51% | +1012.79% |
| Sep 15, 2026 | $9.00 | +1082.65% | $3.21 | -86.01% | +1168.66% |
| Sep 14, 2026 | $11.63 | +1428.25% | $3.55 | -84.53% | +1512.78% |
| Sep 11, 2026 | $8.61 | +1031.41% | $3.97 | -82.70% | +1114.11% |
| Sep 10, 2026 | $6.18 | +712.09% | $4.05 | -82.35% | +794.44% |
| Sep 09, 2026 | $5.98 | +685.81% | $6.60 | -71.24% | +757.05% |
| Sep 08, 2026 | $- | $9.37 | -59.17% | - | |
| Sep 04, 2026 | $0.24 | -68.33% | $14.15 | -38.34% | -29.99% |
| Sep 03, 2026 | $0.25 | -66.89% | $12.32 | -46.32% | -20.57% |
| Sep 02, 2026 | $0.28 | -62.81% | $13.21 | -42.46% | -20.35% |
| Sep 01, 2026 | $0.29 | -62.02% | $12.48 | -45.64% | -16.38% |
Page 1 of 17